Ecoeye Co., Ltd. (KOSDAQ:448280)
6,750.00
-830.00 (-10.95%)
At close: Jul 20, 2026
Ecoeye Revenue
Ecoeye had revenue of 5.38B KRW in the quarter ending March 31, 2026, with 51.72% growth. This brings the company's revenue in the last twelve months to 32.75B, up 35.47% year-over-year. In the year 2025, Ecoeye had annual revenue of 30.92B with 19.97% growth.
Revenue (ttm)
32.75B
Revenue Growth
+35.47%
P/S Ratio
6.11
Revenue / Employee
712.00M
Employees
46
Market Cap
200.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.92B | 5.15B | 19.97% |
| Dec 31, 2024 | 25.77B | -39.05B | -60.25% |
| Dec 31, 2023 | 64.82B | 4.70B | 7.82% |
| Dec 31, 2022 | 60.12B | 33.13B | 122.72% |
| Dec 31, 2021 | 26.99B | 17.44B | 182.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TOVIS Co.,Ltd | 656.32B |
| Mirai Semiconductors | 478.59B |
| Han Kook Capital. | 218.57B |
| INFINITT Healthcare | 110.02B |
| KNJ Co., Ltd. | 100.03B |
| Au Brandz Co.,Ltd | 70.66B |
| Chips&Media | 28.88B |
| Penetrium Bioscience | 9.74B |